Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Eckhardt, Christina M., Cummings, Matthew J., Rajagopalan, Kartik N., Borden, Sarah, Bitan, Zachary C., Wolf, Allison, Kantor, Alex, Briese, Thomas, Meyer, Benjamin J., Jacobson, Samuel D., Scotto, Dawn, Mishra, Nischay, Philip, Neena M., Stotler, Brie A., Schwartz, Joseph, Shaz, Beth, Spitalnik, Steven L., Eisenberger, Andrew, Hod Jessica Justman, Eldad A., Cheung, Ken, Lipkin, W. Ian, O’Donnell, Max R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670989/
https://www.ncbi.nlm.nih.gov/pubmed/33203476
http://dx.doi.org/10.1186/s13063-020-04877-z

Ejemplares similares

Ejemplares similares